Insider · CIK 0001855763
Vanessa Carle
Files at LEXX (Lexaria Bioscience Corp.). First filing Jul 30, 2025, latest Jul 30, 2025.
In brief
Vanessa Carle files SEC Form 4 as officer at LEXX (Lexaria Bioscience Corp.). Since Jul 30, 2025, Vanessa Carle has reported 1 open-market buy worth $683 and 0 open-market sells worth $0, the latest filed on Jul 30, 2025.
A track record needs three past buys with six months of prices behind them; Vanessa Carle has 0, so none is measured yet.
The newest scored trade: bought $683 of LEXX on Jul 29, 2025, filed Jul 30, 2025, scored 56 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LEXX: Lexaria Bioscience Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Lexaria Bioscience Corp. | $683 750 shares | - | +9% from low-75% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | LEXX Lexaria Bioscience Corp. | POpen-market purchase common shares | +750 | $0.91 | $683 | 750 | Jul 30, 2025 |
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +15,000 | $0.00 | $0 | 75,000 | May 16, 2025 |
| Oct 26, 2023 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +12,500 | $0.00 | $0 | 52,567 | Nov 1, 2023 |
Questions about Vanessa Carle
Answered from the filings on this page, as of the latest one.
Is Vanessa Carle buying or selling?
Not in the last 12 months. Vanessa Carle's latest open-market trade on SEC Form 4 was bought $683 of LEXX on Jul 29, 2025.
How did Vanessa Carle's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vanessa Carle has 0.
Where does Vanessa Carle file Form 4?
Vanessa Carle has filed Form 4 at LEXX (Lexaria Bioscience Corp.) as Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.